GFL Ltd., a leading player in the pharmaceutical sector, has announced a significant expansion at its facility in Ranjitnagar, Panchmahal, Gujarat. The company will invest ₹50 crores to enhance its production capacity of pharmaceutical intermediates. This expansion aims to cater to the growing demand for these critical components in the pharmaceutical supply chain.
The project, set to increase the facility's output to 6050 metric tons per annum (TPA), underscores GFL Ltd.'s commitment to strengthening its market position and meeting global standards of quality and efficiency. Pharmaceutical intermediates are crucial in the production of active pharmaceutical ingredients (APIs), which form the backbone of drug manufacturing.
According to company sources, this expansion aligns with GFL Ltd.'s strategic vision to capitalize on emerging opportunities in the pharmaceutical sector, both domestically and internationally. The investment not only aims to boost production but also enhance research and development capabilities, ensuring continued innovation and competitiveness in the market.
With construction already underway, GFL Ltd. expects the expanded facility to be operational by [mention timeline if available], marking a significant milestone in its growth trajectory. This development is anticipated to create employment opportunities in the region and contribute to Gujarat's status as a pharmaceutical hub.
News by Rahul Yelligetti